Stoke Therapeutics, Inc. (STOK)

35.97 +0.36 (+1.01%) USD  |  NASDAQ  |  Apr 22, 13:51
More

Stoke Therapeutics Underperform Recommendations

Underperform Recommendations Chart

View Underperform Recommendations for STOK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Underperform Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Underperform Recommendations Range, Past 5 Years

View Underperform Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Underperform Recommendations Benchmarks

View Underperform Recommendations Benchmarks
Start Trial
Biogen, Inc. Upgrade
Krystal Biotech, Inc. Upgrade
Scholar Rock Holding Corp. Upgrade
Vertex Pharmaceuticals, Inc. Upgrade
Zymeworks, Inc. Upgrade